Drug Shortage Report for SOLU-CORTEF

Last updated on 2022-09-13 History
Report ID 164588
Drug Identification Number 00030627
Brand name SOLU-CORTEF
Common or Proper name SOLU-CORTEF
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) HYDROCORTISONE
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 4mL vial
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-09
Estimated end date
Actual end date 2022-09-12
Shortage status Resolved
Updated date 2022-09-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-09-13 French Compare
v13 2022-09-13 English Compare
v12 2022-09-10 English Compare
v11 2022-09-01 French Compare
v10 2022-09-01 English Compare
v9 2022-08-30 English Compare
v8 2022-08-23 French Compare
v7 2022-08-23 English Compare
v6 2022-08-23 English Compare
v5 2022-08-17 French Compare
v4 2022-08-17 English Compare
v3 2022-08-16 English Compare
v2 2022-07-14 French Compare
v1 2022-07-14 English Compare

Showing 1 to 14 of 14